These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24293049)

  • 1. Major and minor neurocognitive disorders in DSM-5: the difference between the map and the terrain.
    Looi JC; Velakoulis D
    Aust N Z J Psychiatry; 2014 Mar; 48(3):284-6. PubMed ID: 24293049
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurocognitive disorders in DSM-5: a critical review].
    Van Assche L; Persoons P; Vandenbulcke M
    Tijdschr Psychiatr; 2014; 56(3):211-6. PubMed ID: 24643834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment nonadherence and neurocognitive impairment in bipolar disorder.
    Martinez-Aran A; Scott J; Colom F; Torrent C; Tabares-Seisdedos R; Daban C; Leboyer M; Henry C; Goodwin GM; Gonzalez-Pinto A; Cruz N; Sanchez-Moreno J; Vieta E
    J Clin Psychiatry; 2009 Jul; 70(7):1017-23. PubMed ID: 19497247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11.
    Sachdev P; Andrews G; Hobbs MJ; Sunderland M; Anderson TM
    Psychol Med; 2009 Dec; 39(12):2001-12. PubMed ID: 19796426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intellectual processes in the DSM-V diagnosis of ADHD.
    Naglieri JA; Goldstein S
    J Atten Disord; 2006 Aug; 10(1):3-8. PubMed ID: 16840587
    [No Abstract]   [Full Text] [Related]  

  • 7. Comorbid anxiety corresponds with neuropsychological dysfunction in unipolar depression.
    Basso MR; Lowery N; Ghormley C; Combs D; Purdie R; Neel J; Davis M; Bornstein R
    Cogn Neuropsychiatry; 2007 Sep; 12(5):437-56. PubMed ID: 17691001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive disorders in DSM-5.
    Blazer D
    Am J Psychiatry; 2013 Jun; 170(6):585-7. PubMed ID: 23732964
    [No Abstract]   [Full Text] [Related]  

  • 9. A validation study of depressive syndromes in Parkinson's disease.
    Starkstein SE; Merello M; Jorge R; Brockman S; Bruce D; Petracca G; Robinson RG
    Mov Disord; 2008 Mar; 23(4):538-46. PubMed ID: 18074376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of the diagnostic manual-intellectual disability for mental disorders in persons with intellectual disability: results from a brief field survey.
    Fletcher RJ; Havercamp SM; Ruedrich SL; Benson BA; Barnhill LJ; Cooper SA; Stavrakaki C
    J Clin Psychiatry; 2009 Jul; 70(7):967-74. PubMed ID: 19497248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we fix PTSD in DSM-V?
    McNally RJ
    Depress Anxiety; 2009; 26(7):597-600. PubMed ID: 19569228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cognition in dysthymia].
    Harris P; Allegri RF; Dillon C; Serrano CM; Loñ L; Villar V; Lopez Amalfara L; Butman J; Taragano FE
    Vertex; 2005; 16(61):165-9. PubMed ID: 15957010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Did I say that word or did you? Executive dysfunctions in schizophrenic patients affect memory efficiency, but not source attributions.
    Peters MJ; Cima MJ; Smeets T; de Vos M; Jelicic M; Merckelbach H
    Cogn Neuropsychiatry; 2007 Sep; 12(5):391-411. PubMed ID: 17690998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder.
    Jaeger J; Berns S; Loftus S; Gonzalez C; Czobor P
    Bipolar Disord; 2007; 9(1-2):93-102. PubMed ID: 17391353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of Alzheimer's disease].
    Namba Y
    Nihon Rinsho; 2004 Jan; 62 Suppl():61-5. PubMed ID: 15011321
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic and Statistical Manual of Mental Disorders-5: implications for older adults and their families.
    Sorrell JM
    J Psychosoc Nurs Ment Health Serv; 2013 Mar; 51(3):19-22. PubMed ID: 23459094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits.
    Ritsner MS; Blumenkrantz H
    Psychiatry Res; 2007 Jan; 149(1-3):59-69. PubMed ID: 17137634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive disorders in DSM 5 project - personal comments.
    Bajenaru O; Tiu C; Antochi F; Roceanu A
    J Neurol Sci; 2012 Nov; 322(1-2):17-9. PubMed ID: 22910146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.